On Thursday, March 28th from 6:30 to 9:00 p.m., Shanghai Healthcare Drinks, ChinaBio and Bayer will hold a discussion panel entitled “BioPharma Investment and Partnering in China”. The event will be hosted by Bayer at their Shanghai Pudong Office. 

This event is a warm up for the ChinaBio Partnering Forum held on May 8th-9th in Shanghai. Use the 'CHD20' code to get the Healthcare Drinks 20% discount on tickets.

The panel will be moderated by Greg Scott, Founder and Chairman of ChinaBio and consist of the following executives:

* Betty Huang - Head of Business Development and Licensing APAC, Bayer
* Mark Xu - Founder & CEO, Xynomic Pharma
* Robert Braithwaite - Founder and CEO of Luqa Pharmaceuticals
* Robin Zhang - Vice President of Business Development, Tasly 
* William Cao - Founder & CEO, Gracell Bio
 

Prior to the panel, Greg Scott will give the latest updates on the industry with his talk entitled "China Life Science Investment: Good Times Keep Rolling".

Cross border partnering, M&A and investment for China's pharmaceutical and biotech companies were on fire at the beginning of last year. Given recent changes in global investment, economic and regulatory environments, will this hot streak continue? What adjustments, if any should, be made in order for biopharma companies large and small to maximise the value of new partnerships in 2019?